Michael B. Hoffman - 24 Nov 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Maria Maccecchini Attorney-in-Fact
Issuer symbol
ANVS
Transactions as of
24 Nov 2025
Net transactions value
+$159,886
Form type
4
Filing time
25 Nov 2025, 12:26:46 UTC
Previous filing
21 Nov 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman Michael B Director C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN /s/ Maria Maccecchini Attorney-in-Fact 25 Nov 2025 0001290208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Purchase $6,150 +1,489 +0.06% $4.13 2,482,028 24 Nov 2025 Direct
transaction ANVS Common Stock Purchase $35,420 +9,200 +0.37% $3.85 2,491,228 24 Nov 2025 Direct
transaction ANVS Common Stock Purchase $1,718 +415 +0.02% $4.14 2,491,643 24 Nov 2025 Direct
transaction ANVS Common Stock Purchase $116,598 +28,096 +1.1% $4.15 2,519,739 24 Nov 2025 Direct
holding ANVS Common Stock 223,357 24 Nov 2025 The 2018 Jane and Michael Hoffman Descendants Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.